Clinical Research Education for Drug Abuse Professionals

药物滥用专业人员的临床研究教育

基本信息

  • 批准号:
    8433405
  • 负责人:
  • 金额:
    $ 22.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-03-01 至 2016-02-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This new application is submitted to initiate a Clinical Research Education for Drug Abuse Professionals (CREDAP) training program at Baylor College of Medicine, based on the successful CREDAP that was previously sited at UCLA. The overarching goal is to provide a coordinated, sustainable infrastructure of dedicated education and training that will produce independent healthcare professionals capable of conducting and disseminating clinical research pertaining to drug dependence and its treatment. This extensively revised application features an expansion of available mentors and research opportunities to include Pre-Clinical Human Pharmacology and Medications Testing (Drs. Newton, De La Garza), Brain Imaging and Cognitive Neuroscience (Drs. Moeller, Lane, and Steinberg), Neurogenetics (Dr. Nielson), Neurochemical Correlates of Addiction (Dr. Little) and Clinical Trials Research (Dr. Kosten). In addition, the program includes more extensive mechanisms of ensuring accountability of both faculty and trainees with the goal of consistently producing trainees that are able to successfully compete for funding. The specific aims of the program are: 1. to provide trainees with a comprehensive understanding of drug abuse research and clinical practice, entailing interdisciplinary clinical research education and training lasting two years at post-doctoral level under the guidance of preceptors. 2. To educate trainees to have full competence in using experimental techniques appropriate for the investigation of drug abuse, emphasizing advanced technologies, procedural reliability, and validity. 3. To encourage trainees to investigate a defined clinical research issue in drug abuse, with a focus on clinical trials research, starting them on a course of clinical research that will continue beyond the 2-year program. 4. To prepare trainees to become productive clinical researchers by teaching them to prepare manuscripts reporting research results that merit publication in peer-reviewed, high-quality biomedical journals, to write and submit grant applications to the NIH, and to become part of national research communities by attending meetings, seminars, and symposia where they may present research, gain new knowledge, and forge new collaborations. 5. To increase diversity in the training program through identifying and soliciting applications from promising candidates from underrepresented populations, including racial/ethnic groups and women. 6. To further develop and refine the program through formal evaluation efforts that provide input on areas that can be improved.
描述(由申请人提供):提交此新申请是为了在贝勒医学院启动药物滥用专业人员临床研究教育(CREDAP)培训计划,该计划基于先前在加州大学洛杉矶分校成功举办的CREDAP。总体目标是提供一个协调、可持续的专门教育和培训基础设施,培养能够开展和传播有关药物依赖及其治疗的临床研究的独立医疗保健专业人员。这一广泛修订的应用程序的特点是可用的导师和研究机会的扩展,包括临床前人类药理学和药物测试(牛顿博士,德拉加尔萨),脑成像和认知神经科学(Moeller博士,莱恩和斯坦伯格),神经遗传学(尼尔森博士),成瘾的神经化学相关性(利特尔博士)和临床试验研究(科斯坦博士)。此外,该方案包括更广泛的机制,确保教师和学员的问责制,目标是不断培养能够成功竞争资金的学员。该计划的具体目标是:1。使学员全面了解药物滥用研究和临床实践,需要在导师的指导下进行为期两年的博士后水平的跨学科临床研究教育和培训。2.教育受训人员有充分的能力,使用适当的调查药物滥用的实验技术,强调先进的技术,程序的可靠性和有效性。3.为了鼓励学员调查药物滥用中定义的临床研究问题,重点是临床试验研究,开始他们的临床研究课程,将持续超过2年的计划。4.通过教他们准备报告值得在同行评审,高质量的生物医学期刊上发表的研究结果的手稿,编写并向NIH提交资助申请,并通过参加会议,研讨会和研讨会成为国家研究社区的一部分,他们可以在那里展示研究,获得新知识,并建立新的合作。5.通过从代表性不足的人群,包括种族/族裔群体和妇女中确定和征求有前途的候选人的申请,增加培训方案的多样性。6.通过正式的评估工作,进一步发展和完善该计划,为可以改进的领域提供投入。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas Frederick Newton其他文献

Thomas Frederick Newton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas Frederick Newton', 18)}}的其他基金

Triple Re-uptake Inhibitor, SKL 10406, as a New Treatment for Alcohol Dependence
三重再摄取抑制剂 SKL 10406,作为酒精依赖的新治疗方法
  • 批准号:
    8834162
  • 财政年份:
    2015
  • 资助金额:
    $ 22.25万
  • 项目类别:
Carisbamate Treatment for Alcohol Dependence
Carisbamate 治疗酒精依赖
  • 批准号:
    8735477
  • 财政年份:
    2013
  • 资助金额:
    $ 22.25万
  • 项目类别:
Carisbamate Treatment for Alcohol Dependence
Carisbamate 治疗酒精依赖
  • 批准号:
    8455440
  • 财政年份:
    2013
  • 资助金额:
    $ 22.25万
  • 项目类别:
Carisbamate Treatment for Alcohol Dependence
Carisbamate 治疗酒精依赖
  • 批准号:
    8900485
  • 财政年份:
    2013
  • 资助金额:
    $ 22.25万
  • 项目类别:
Clinical Research Education for Drug Abuse Professionals
药物滥用专业人员的临床研究教育
  • 批准号:
    8231271
  • 财政年份:
    2011
  • 资助金额:
    $ 22.25万
  • 项目类别:
Clinical Research Education for Drug Abuse Professionals
药物滥用专业人员的临床研究教育
  • 批准号:
    8624682
  • 财政年份:
    2011
  • 资助金额:
    $ 22.25万
  • 项目类别:
Clinical Research Education for Drug Abuse Professionals
药物滥用专业人员的临床研究教育
  • 批准号:
    7861881
  • 财政年份:
    2011
  • 资助金额:
    $ 22.25万
  • 项目类别:
N-ACETYLCYSTEINE AS A POTENTIAL TREATMENT FOR METHAMPHETAMINE DEPENDENCE
N-乙酰半胱氨酸作为甲基苯丙胺依赖的潜在治疗方法
  • 批准号:
    8356780
  • 财政年份:
    2010
  • 资助金额:
    $ 22.25万
  • 项目类别:
THE EFFECTS OF DOXAZOSIN ON THE CARDIOVASCULAR AND SUBJECTIVE EFFECTS OF COCAINE
多沙唑嗪对心血管的影响和可卡因的主观影响
  • 批准号:
    8356781
  • 财政年份:
    2010
  • 资助金额:
    $ 22.25万
  • 项目类别:
AN ACE INHIBITOR AS A TREATMENT FOR METHAMPHETAMINE DEPENDENCE
ACE 抑制剂治疗甲基苯丙胺依赖
  • 批准号:
    8356772
  • 财政年份:
    2010
  • 资助金额:
    $ 22.25万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 22.25万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 22.25万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.25万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.25万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 22.25万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.25万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 22.25万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 22.25万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 22.25万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.25万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了